2015
DOI: 10.1371/journal.pone.0122977
|View full text |Cite
|
Sign up to set email alerts
|

Hyperthermia Induces Apoptosis of 786-O Cells through Suppressing Ku80 Expression

Abstract: Hyperthermia as an anticancer method has been paid increasing attention in recent years. Several studies have shown that hyperthermia can kill tumor cells by inducing apoptosis. However, the underlying molecular mechanisms of hyperthermia-induced apoptosis are largely unknown. To investigate the effects and molecular mechanism of hyperthermia on the apoptosis in renal carcinoma 786-O cells, we firstly examined apoptosis and Ku expression in 786-O cell line treated with heat exposure (42°C for 0-4 h). The resul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 42 publications
1
18
0
Order By: Relevance
“…Analysis of cell cycle revealed increased presence of HT29 cells in G 2 /M phase after heat shock application, while combination of hyperthermia with auraptene resulted in considerable accumulation of cells in sub G 1 /G 1 phase. In consistence with our findings, G 2 /M phase arrest was reported after hyperthermia in several cell types such as liver, lung, breast and renal cancer cells (Qi et al 2015;Zhao et al 2015;Yan et al 2014;Lin et al 2013). Same as present results, previous studies have also indicated growth controlling effects of auraptene on breast and gastric carcinoma cells by cell cycle arrest in sub G 1 (Mousavi et al 2015, Moon et al 2015 and G 0 -G 1 phases (de Medina et al 2010;Krishnan et al 2009).…”
Section: R a F Tsupporting
confidence: 91%
“…Analysis of cell cycle revealed increased presence of HT29 cells in G 2 /M phase after heat shock application, while combination of hyperthermia with auraptene resulted in considerable accumulation of cells in sub G 1 /G 1 phase. In consistence with our findings, G 2 /M phase arrest was reported after hyperthermia in several cell types such as liver, lung, breast and renal cancer cells (Qi et al 2015;Zhao et al 2015;Yan et al 2014;Lin et al 2013). Same as present results, previous studies have also indicated growth controlling effects of auraptene on breast and gastric carcinoma cells by cell cycle arrest in sub G 1 (Mousavi et al 2015, Moon et al 2015 and G 0 -G 1 phases (de Medina et al 2010;Krishnan et al 2009).…”
Section: R a F Tsupporting
confidence: 91%
“…In addition to surgery, chemotherapy, radiation and biological therapy, hyperthermia has become a leading strategy for the treatment of cancer, and is a key part of multidisciplinary therapy ( 9 ). In RCC, hyperthermia is accepted as an alternative method to surgery in certain patients who are not suitable as surgical candidates ( 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…The potential mechanisms regarding inhibited proliferation are considered to involve the suppression of tumor cell replication and metabolism. For instance, in the renal cell carcinoma (RCC) cell line 786-O, hyperthermia exposure suppressed Ku80 expression and lead to G2/M phase cell cycle arrest, which may represent a potential mechanism of hyperthermia-mediated suppression of proliferation ( 9 ).…”
Section: Introductionmentioning
confidence: 99%
“…Apoptosis is the autonomous process of programmed cell death controlled by gene expression, which functions to regulate and maintain a stable internal environment in multicellular organisms. Previous studies have demonstrated that hyperthermia induces apoptosis in tumor cells (4,8,9). Hyperthermia at 40-45˚C was observed to induce apoptosis-mediated cell death in tumor cells, with no significant influence on normal tissues, while hyperthermia at temperatures >45˚C was identified to induce necrosis-mediated cell death with additional damage to normal tissues (10,11).…”
Section: Introductionmentioning
confidence: 94%